Back to Results
First PageMeta Content
Pharmacology / Food and Drug Administration / Pharmaceutical industry / Clinical research / Clinical pharmacology / Medical device / Alternative medicine / Center for Devices and Radiological Health / Clinical trial / Pharmaceutical sciences / Medicine / Health


This report replaces the version posted on March 16, 2004. It contains a revised Figure 2, which now reflects fiscal year data for both BLAs and NMEs, and minor editorial changes. INNOVATION OR STAGNATION TABLE OF CONT
Add to Reading List

Document Date: 2014-02-20 17:49:57


Open Document

File Size: 1,03 MB

Share Result on Facebook

City

Boston / /

Currency

USD / /

IndustryTerm

technology discovery process / biological products / effort required to create better tools / biologic applications / targeted solutions / medical products / fewer new products / technology development process / medical device applications / investigational products / biomedical science to medical product / therapies for uncommon diseases / predictive tools / medical technology / /

MedicalCondition

less common diseases / prevalent third world diseases / diseases / disease / uncommon diseases / /

MedicalTreatment

antibiotics / /

Organization

FDA / Congress / Food and Drug Administration / Tufts Center for the Study of Drug Development / /

Position

Executive / CONTENTS EXECUTIVE / /

PublishedMedium

the Business / /

Technology

genomics / bioinformatics / human genome / Drug Development / /

URL

http /

SocialTag